Cargando…

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Qin, Ya-Zhen, Jiang, Qian, Wang, Yu, Jiang, Hao, Xu, Lan-Ping, Zhao, Xiao-Su, Zhang, Xiao-Hui, Liu, Kai-Yan, Huang, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016839/
https://www.ncbi.nlm.nih.gov/pubmed/33795645
http://dx.doi.org/10.1038/s41408-021-00461-z
_version_ 1783673936742973440
author Qin, Ya-Zhen
Jiang, Qian
Wang, Yu
Jiang, Hao
Xu, Lan-Ping
Zhao, Xiao-Su
Zhang, Xiao-Hui
Liu, Kai-Yan
Huang, Xiao-Jun
author_facet Qin, Ya-Zhen
Jiang, Qian
Wang, Yu
Jiang, Hao
Xu, Lan-Ping
Zhao, Xiao-Su
Zhang, Xiao-Hui
Liu, Kai-Yan
Huang, Xiao-Jun
author_sort Qin, Ya-Zhen
collection PubMed
description
format Online
Article
Text
id pubmed-8016839
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80168392021-04-16 The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia Qin, Ya-Zhen Jiang, Qian Wang, Yu Jiang, Hao Xu, Lan-Ping Zhao, Xiao-Su Zhang, Xiao-Hui Liu, Kai-Yan Huang, Xiao-Jun Blood Cancer J Correspondence Nature Publishing Group UK 2021-04-01 /pmc/articles/PMC8016839/ /pubmed/33795645 http://dx.doi.org/10.1038/s41408-021-00461-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Qin, Ya-Zhen
Jiang, Qian
Wang, Yu
Jiang, Hao
Xu, Lan-Ping
Zhao, Xiao-Su
Zhang, Xiao-Hui
Liu, Kai-Yan
Huang, Xiao-Jun
The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title_full The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title_fullStr The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title_full_unstemmed The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title_short The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
title_sort impact of the combination of kit mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016839/
https://www.ncbi.nlm.nih.gov/pubmed/33795645
http://dx.doi.org/10.1038/s41408-021-00461-z
work_keys_str_mv AT qinyazhen theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT jiangqian theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT wangyu theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT jianghao theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT xulanping theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT zhaoxiaosu theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT zhangxiaohui theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT liukaiyan theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT huangxiaojun theimpactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT qinyazhen impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT jiangqian impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT wangyu impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT jianghao impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT xulanping impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT zhaoxiaosu impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT zhangxiaohui impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT liukaiyan impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia
AT huangxiaojun impactofthecombinationofkitmutationandminimalresidualdiseaseonoutcomeint821acutemyeloidleukemia